Skip to Content

Clinical Trials

Updated 1/25/2011

Esophageal Cancer

 ACOSOGZ4051: A Phase II Study of Neoadjuvant Therapy with Cisplatin, Docetaxel, Panitumumab Plus Radiation Therapy Followed by Surgery in Patients with Locally Advanced Adenocarcinoma of the Distal Esophagus.

2004-0703: An Oxaliplatin-based Phase II Randomized Study of Induction Chemotherapy Followed by Preoperative Chemotherapy or Preoperative Chemoradiotherapy in Patients with Resectable Esophageal or Gastroesophageal Carcinoma

Lung Cancer

2007-0353: Prospective Comparison of Endobronchial Ultrasound Needle Biopsy versus Mediastinoscopy for Staging of Mediastinal Nodes in Patients with Clinical Stage IIIA Non-small Cell Lung Cancer. 

2007-0865: A Double- Blind, Randomized, Placebo-Controlled Phase III Study to Assess the Efficacy of recMAGE-A3 + AS15 Antigen-Specific Cancer Immunotherapeutic as Adjuvant therapy in Patients with Resectable MAGE-A3-Positive Non Small Cell Lung Cancer. (GSK Study # 109493) 

2007-0870: International randomized study to Compare CyberKnife® Stereotactic Radiosurgery with Surgical Resection in Stage I Non-small Cell Lung Cancer. 

2009-0591: A Double Blinded, Randomized Study Comparing the Effectiveness of Fish Oil Supplements, Oral Statins, and Placebo in Reducing the Incidence of Atrial Fibrillation Following a Lung Resection in Patients with Lung Cancer

2007-0387: Diagnostic utility of endobronchial ultrasound guided mediastinal lymph node sampling in clinical Stage I and II Non Small Cell Lung Cancer


2006-0935: Phase I Trial of Induction Dasatinib Therapy in Patients with Resectable Malignant Pleural Mesothelioma

© 2014 The University of Texas MD Anderson Cancer Center